发明名称 LTA4 HYDROLASE INHIBITORS
摘要 The present invention provides compounds having the structure: Ar1-Q-Ar2-O- (CH2)n-Z and pharmaceutically acceptable salts and stereoisomers thereof that are useful in the treatment of inflammatory diseases which are mediated by LTB4 production, such as psoriasis, ulcerative colitis, IBD, and asthma.
申请公布号 CA2282710(A1) 申请公布日期 1998.09.17
申请号 CA19982282710 申请日期 1998.03.06
申请人 G.D. SEARLE & CO. 发明人 RUSSELL, MARK A.;CHEN, HELEN;CHEN, BARBARA B.
分类号 C07D295/12;A61K31/155;A61K31/4164;A61K31/4184;A61K31/445;A61K31/4453;A61P1/04;A61P11/06;A61P17/06;A61P29/00;A61P43/00;C07C255/12;C07C257/06;C07C257/14;C07C259/14;C07D211/62;C07D233/10;C07D233/18;C07D233/22;C07D235/12;C07D295/185;(IPC1-7):C07D295/08 主分类号 C07D295/12
代理机构 代理人
主权项
地址